Big Pharma

Patients suffering with hard-to-treat depression may get relief from noninvasive magnetic brain stimulation Autoría Patricia Junquera Associate Professor and Vice Chair of Clinical Services, Florida International University Not only is depression a debilitating disease, but it is also widespread. Approximately 20 million adult Americans experience at least one episode of depression per year. Millions of them take medication to treat their depression. But for many, the medications don’t work: Either they have minimal or no effect, or the side effects are intolerable. These patients have what is called treatment-resistant depression. One promising treatment for such patients is a type of brain...

Treating mental illness with electricity marries old ideas with modern tech and understanding of the brain – podcast   Autoría Daniel Merino Assistant Science Editor & Co-Host of The Conversation Weekly Podcast, The Conversation Gemma Ware Editor and Co-Host, The Conversation Weekly Podcast, The Conversation Entrevista Jacinta O'Shea Associate Professor and Wellcome/Royal Society Sir Henry Dale Fellow, University of Oxford Joseph J. Fins The E. William Davis Jr, M.D. Professor of Medical Ethics and Professor of Medicine at Weill Cornell Medicine, Cornell University Rachel A. Davis Associate Professor of Psychiatry and Neurosurgery, University of Colorado Anschutz Medical Campus Mental illnesses such...

Poor glycemic control in patients with type 2 diabetes can be predicted from patient information systems with the help of machine learning The risk for poor glycemic control in patients with type 2 diabetes can be predicted with confidence by using machine learning methods, a new study from Finland finds. The most important factors predicting glycemic control include prior glucose levels, duration of type 2 diabetes, and the patient’s existing anti-diabetic medicines. The researchers examined glycaemic control in patients with type 2 diabetes in North Karelia, Finland, over a period of six years. Patients’ glycemic control was determined on the...

Calibre Scientific Acquires Carvalhaes, a Distributor of Laboratory Consumables and Scientific Equipment in Brazil LOS ANGELES, Dec, 2022 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of Carvalhaes (the “Company”), a Brazilian distributor of laboratory consumables and scientific equipment. Carvalhaes, Calibre Scientific’s first acquisition in Latin America, further expands Calibre Scientific’s global distribution platform. Founded in 1996, Carvalhaes serves a broad customer base that spans pharmaceutical, veterinary, research, food, environmental, and industrial sectors. Carvalhaes offers a differentiated portfolio of more than 200,000 products, including chromatography supplies, chemicals, test kits and standards, glassware, and consumables; all delivered with care through...

 4 Pillars of Self-Care for Stress, Anxiety, Depression and Grief     San Antonio, TX, December 2022 — Advancements in medicine, science and technology have had tremendous impacts on improved patient outcomes, and yet, certain conditions remain particularly challenging to treat, notes Dr. Jan Patterson in the introduction to the new book, Breath for the Soul: Self-Care Steps to Wellness.   “Many times, there’s a need for something more,” she said. “In my training with integrative medicine, I’ve learned that there are simple yet effective things that we can do with our breath, movement, nutrition, spirit and mindfulness to help...